Free Trial

Organogenesis (ORGO) Stock Forecast & Price Target

$2.91
-0.04 (-1.36%)
(As of 04:28 PM ET)

Organogenesis - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$4.88
67.53% Upside
High Forecast$6.00
Average Forecast$4.88
Low Forecast$3.50
TypeCurrent Forecast
7/13/23 to 7/12/24
1 Month Ago
6/13/23 to 6/12/24
3 Months Ago
4/14/23 to 4/13/24
1 Year Ago
7/13/22 to 7/13/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$4.88$4.83$4.83$10.00
Forecasted Upside67.53% Upside47.81% Upside47.81% Upside190.70% Upside
Get Organogenesis Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter.

ORGO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ORGO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Organogenesis Stock vs. The Competition

TypeOrganogenesisMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.71
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside63.59% Upside939.19% Upside9.38% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/28/2024Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. O'neil
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$5.00+89.39%
3/1/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Osborn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$5.00+47.06%
12/27/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$4.00 ➝ $6.00+51.13%
11/14/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$3.00 ➝ $3.50+43.44%
8/10/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:11 PM ET.

ORGO Forecast - Frequently Asked Questions

What is Organogenesis' forecast for 2024?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Organogenesis is $4.88, with a high forecast of $6.00 and a low forecast of $3.50.

Should I buy or sell Organogenesis stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organogenesis in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ORGO shares.

Does Organogenesis's stock price have much upside?

According to analysts, Organogenesis's stock has a predicted upside of 56.63% based on their 12-month stock forecasts.

What analysts cover Organogenesis?

Organogenesis has been rated by research analysts at Lake Street Capital in the past 90 days.

Do Wall Street analysts like Organogenesis more than its competitors?

Analysts like Organogenesis more than other "medical" companies. The consensus rating score for Organogenesis is 2.75 while the average consensus rating score for "medical" companies is 2.71. Learn more on how ORGO compares to other companies.


This page (NASDAQ:ORGO) was last updated on 7/12/2024 by MarketBeat.com Staff

From Our Partners